Researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg have identified a previously undocumented, organ-specific toxicity linked to CD19-targeted CAR T-cell therapy in autoimmune disease. The syndrome, termed ...
Researchers at the First Affiliated Hospital of Chongqing Medical University in China have uncovered a sharply rising burden of skin cancer in older adults driven largely by population growth and affecting men twice as often.
Most humans can recall specific events and past experiences for long periods of time. This capability, referred to as episodic memory, is known to be in great part supported by the activity of neurons in the hippocampus and ...
Fujita Health University scientists found that the type of food consumed affects eating speed more than the sequence in which food is eaten. Meals served in individual portions and eaten with utensils prompted longer meal ...
University of Alabama at Birmingham-led researchers have refined and validated a new framework for diagnosing chronic obstructive pulmonary disease (COPD), identifying individuals at risk for severe respiratory outcomes who ...
Height is one of the most evident sex-based differences observed in humans, as men are on an average 13 cm (5 inches) taller than women. Sex hormones certainly play a significant role in driving this dimorphism, but they ...
Mold thrives where moisture lingers. Spores can flourish after floods, heavy rains, or the unseen drip of a leaky pipe, turning bathrooms, bedrooms, and air-conditioning units into fungal incubators. Behind drywall, around ...
Memorial Sloan Kettering Cancer Center investigators report that T cell interferon-γ (IFNγ) orchestrates a dendritic-cell–natural-killer-cell circuit that suppresses leptomeningeal metastases in mouse models.
Duke University Medical Center-led research has identified a human-specific DNA enhancer that regulates neural progenitor proliferation and cortical size. Small genetic changes in HARE5 amplify a key developmental pathway, ...
Yonsei University College of Medicine-led research has shown amiloride is as effective as spironolactone in reducing systolic blood pressure (SBP) over 12 weeks in patients with resistant hypertension.
